GRT-C901 drug page Clinical trials

Trials with GRT-C901

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

2Trials
0Recruiting
2Countries
729Planned patients
All 2 Ongoing, not recruiting 1 Finished 1
Phase All Phase 1 1 Phase 2 1

Showing 1–2 of 2

A Study of a Patient-Specific Neoantigen Vaccine in Combination With Immune Checkpoint Blockade for Patients With Metastatic Colorectal Cancer
Ongoing, not recruiting Phase 2 700 patients NCT05141721

The primary objective of the Phase 2 portion of the study is to characterize the clinical activity of maintenance therapy with GRT-C901/GRT-R902 (patient-specific vaccines) in combination with checkpoint inhibitors in addition to fluoropyr…

United States Feb 2022 – Mar 2027 Interventional
Combined with: AtezolizumabBevacizumabGrt-r902IpilimumabLeucovorin
See the trial ClinicalTrials.gov Am I eligible?
A Study of a Personalized Neoantigen Cancer Vaccine
Finished Phase 1 29 patients NCT03639714

The purpose of this study is to evaluate the safety, dose, immunogenicity and early clinical activity of GRT-C901 and GRT-R902, a personalized neoantigen cancer vaccine, in combination with nivolumab and ipilimumab, in patients with metast…

United States, Australia Feb 2019 – Nov 2022 Interventional
Combined with: Grt-r902IpilimumabNivolumab
See the trial ClinicalTrials.gov Am I eligible?